StonvexLoading…
StonvexStonvexStonvexCore line items from AIMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $124.16K | $20.73K | $122.11K | $3.52M |
Operating Income | $-13.99M | $-13.84M | $-13.21M | $-13.98M |
Net Income | $-14.77M | $-14.86M | $-13.77M | $-14.01M |
EPS (Diluted) | $-3.46 | $-7.82 | $-3.36 | Not available |
Total Assets | $20.87M | $28.82M | $31.84M | $37.11M |
Total Liabilities | $13.31M | $13.30M | $7.39M | $2.48M |
Cash & Equivalents | $417.35K | $3.89M | $1.89M | $1.85M |
Free Cash Flow OCF − CapEx | $-4.65M | $-5.83M | $-4.79M | $-3.67M |
Shares Outstanding | 5.88M | 3.09M | 4.68M | 4.00M |